Cargando…
Genetically Triggered Thoracic Aortic Disease: Who Should be Tested?
Up to 25% of patients with thoracic aortic disease have an underlying Mendelian pathogenic variant. This is a heterogeneous group of disorders known as heritable thoracic aortic diseases (HTAD). Diagnosing associated pathogenic gene variants and syndromes is critical, as the underlying genetics have...
Autores principales: | Duarte, Valeria E., Yousefzai, Raman, Singh, Michael N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Houston Methodist DeBakey Heart & Vascular Center
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000331/ https://www.ncbi.nlm.nih.gov/pubmed/36910552 http://dx.doi.org/10.14797/mdcvj.1218 |
Ejemplares similares
-
The Role of Genetic Testing in Patients with Heritable Thoracic Aortic Diseases
por: Monda, Emanuele, et al.
Publicado: (2023) -
The genetics and biomechanics of thoracic aortic diseases
por: Harky, Amer, et al.
Publicado: (2019) -
Protecting the spinal cord during thoracic endovascular aortic repair—who should place the spinal drain?
por: Foley, Edward D., et al.
Publicado: (2023) -
Oxidative stress in genetically triggered thoracic aortic aneurysm: role in pathogenesis and therapeutic opportunities
por: Portelli, Stefanie S., et al.
Publicado: (2021) -
The Role of Inflammation and Myeloperoxidase-Related Oxidative Stress in the Pathogenesis of Genetically Triggered Thoracic Aortic Aneurysms
por: Malecki, Cassandra, et al.
Publicado: (2020)